MedPath

Efficacy of submucosal lidocaine injection for shortening procedure time of endoscopic submucosal dissection (ESD) for the treatment of the gastric and colorectal tumor.

Not Applicable
Conditions
Gastric and colorectal tumor which will be removed by ESD.
Registration Number
JPRN-UMIN000022843
Lead Sponsor
Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
225
Inclusion Criteria

Not provided

Exclusion Criteria

1. Severe cardiac disease. 2. Severe kidney disease. 3. Severe infectious disease. 4, Severe diabetes. 5. Severe psychiatric disease. 6. Severe dehydration and nutritional disorder. 7. Patients with bleeding disorders. 8. Patients with severe complications who were determined to be inappropriate to carry out the study. 9. History of hypersensitivity to lidocaine. 10. Patients with tumors which cannot be removed by ESD.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The procedure time of ESD between lidocaine injected group and control group.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath